Luteal-phase support in assisted reproductive technology: An ongoing challenge
- PMID: 34723055
- PMCID: PMC8548747
- DOI: 10.18502/ijrm.v19i9.9708
Luteal-phase support in assisted reproductive technology: An ongoing challenge
Abstract
It has been shown that in controlled ovarian hyper stimulation cycles, defective luteal phase is common. There are many protocols for improving pregnancy outcomes in women undergoing fresh and frozen in vitro fertilization cycles. These approaches include progesterone supplements, human chorionic gonadotropin, estradiol, gonadotropin-releasing hormone agonist, and recombinant luteinizing hormone. The main challenge is luteal-phase support (LPS) in cycles with gonadotropin-releasing hormone agonist triggering. There is still controversy about the optimal component and time for starting LPS in assisted reproductive technology cycles. This review aims to summarize the various protocols suggested for LPS in in vitro fertilization cycles.
Keywords: GnRH agonist; HCG; IVF; Progesterone; Recombinant LH.; Luteal-phase support.
Copyright © 2021 Dashti et al.
Conflict of interest statement
The authors declare that there is no conflict of interest.
References
-
- Practice Committee of the American Society for Reproductive Medicine Current clinical irrelevance of luteal phase deficiency: A committee opinion. Fertil Steril 2015; 103: e27–e32. - PubMed
-
- Casper RF, Yanushpolsky EH. Optimal endometrial preparation for frozen embryo transfer cycles: Window of implantation and progesterone support. Fertil Steril. 2016;105:867–872. - PubMed
-
- Razieh DF, Maryam AR, Nasim T. Beneficial effect of luteal-phase gonadotropin-releasing hormone agonist administration on implantation rate afterintracytoplasmic sperm injection. Taiwan J Obstet Gynecol. 2009;48:245–248. - PubMed
-
- Fatemi HM. Simplifying luteal phase support in stimulated assisted reproduction cycles. Fertil Steril. 2018;110:1035–1036. - PubMed
Publication types
LinkOut - more resources
Full Text Sources